Davis R M Inc. trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,645 shares of the healthcare product maker’s stock after selling 2,452 shares during the period. Davis R M […]

Douglass Winthrop Advisors LLC lifted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 42,978 shares of the healthcare product maker’s stock after buying an additional 1,389 shares during the quarter. Douglass […]

Banco Santander S.A. reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 9.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,893 shares of the healthcare product maker’s stock after selling 1,130 shares during the period. Banco Santander S.A.’s […]

Guardian Wealth Advisors LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 6,157 shares of the healthcare product maker’s stock after acquiring an additional 100 shares during the quarter. Guardian Wealth Advisors […]

S&CO Inc. grew its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 262,646 shares of the healthcare product maker’s stock after purchasing an additional 3,135 shares during the […]

Tower Bridge Advisors increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 45,017 shares of the healthcare product maker’s stock after buying an additional 1,597 shares during the period. Tower Bridge Advisors’ holdings in Abbott […]